Concepedia

J Li

JL

6

Publications

276

Citations

6

H-Index

2008

Active since

Affiliations

University of Cambridge(Current)

Wellcome/MRC Cambridge Stem Cell Institute

Addenbrooke's Hospital

Cambridge University Hospitals NHS Foundation Trust

J Li is an author at University of Cambridge specializing in medicine, jak-stat signaling pathway, and cell biology.

Top concepts

MedicineCell BiologyJak-stat Signaling PathwayCell DeathTumor BiologySystems BiologyApoptosisBreast CancerCancer BiologyCell Signaling

Publications per year

2008–2019

6

Publications

6

Methylation of the suppressor of cytokine signaling 3 gene (SOCS3) in myeloproliferative disorders

Nasios Fourouclas, J Li, Daniel C. Gilby et al. · Haematologica · 2008 · 75 citations · Full text

BET protein inhibition shows efficacy against JAK2V617F-driven neoplasms

B S Wyspiańska, Andrew J. Bannister, Ilaria Barbieri et al. · Leukemia · 2013 · 67 citations · Full text

Bet Protein Inhibition, Tumor Suppressor, Medicine +4

A novel signalling screen demonstrates that CALR mutations activate essential MAPK signalling and facilitate megakaryocyte differentiation

Karoline Kollmann, Wolfgang Warsch, Carlos Gonzalez-Arias et al. · Leukemia · 2016 · 62 citations · Full text

Constitutive activation of JAK2 in mammary epithelium elevates Stat5 signalling, promotes alveologenesis and resistance to cell death, and contributes to tumourigenesis

María M. Caffarel, Rosa Zaragozá, Stefano Pensa et al. · Cell Death and Differentiation · 2011 · 33 citations · Full text

Signal Transduction, Mammary Epithelium, Signaling Pathway +14

JAK2V617F mediates resistance to DNA damage-induced apoptosis by modulating FOXO3A localization and Bcl-xL deamidation

Jin Seok Ahn, J Li, Edwin Chen et al. · Oncogene · 2015 · 28 citations · Full text

Damage-induced Apoptosis, Genome Instability, Cell Regulation +8

Rows per page

1–5 of 6